Aptorum Group Limited is a UK-based biopharmaceutical company that specializes in discovering, developing, and commercializing therapeutic products for the treatment of infectious diseases and cancer. Its pipeline products consist of treatments for various bacterial and viral infections, therapeutic compounds for neuroblastoma and other cancer types, and platforms for metabolic diseases. In addition, Aptorum Group focuses on diagnostic and therapeutic projects in neurology, gastroenterology, women's health, metabolic disorders, and other disease areas.